Cite
HARVARD Citation
He, Y. et al. (2019). CA125 over‐release behavior following a 75‐g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer. International journal of cancer. 145 (6), pp. 1690-1700. [Online].